MANERIX Film-coated tablet Ref.[8223] Active ingredients: Moclobemide

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

Product name and form

Manerix 150mg Film-coated Tablets.

Pharmaceutical Form

Film-coated tablets containing 150mg of moclobemide.

Qualitative and quantitative composition

1 film-coated 150mg tablet contains 150mg moclobemide.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Moclobemide

Moclobemide is an antidepressant which affects the monoaminergic cerebral neurotransmitter system by means of a reversible inhibition of monoamine oxidase preferentially of type A (RIMA).
List of Excipients

Lactose
Maize starch
Povidone K30
Sodium starch glycollate
Magnesium stearate
Hydroxypropyl methylcellulose
Ethylcellulose
Polyethylene glycol 6000
Talc
Titanium dioxide (E171)
Yellow iron oxide (E172)

Pack sizes and marketing

Blister packing.

Pack sizes: 28, 30, 84 and 100 tablets.

Marketing authorization holder

Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

Marketing authorization dates and numbers

PL 46302/0130

9th September 2009

Drugs

Drug Countries
MANERIX Canada, Spain, Ireland, Malta, United Kingdom
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈